Dr. Ronald Alexander Reilkoff, MD

Dr. Reilkoff practices at M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview.

Dr. Reilkoff's NPI, 1003090358, was assigned on December 21, 2007. Dr. Reilkoff graduated from University of North Dakota School of Medicine in 2005. Dr. Reilkoff holds Minnesota license 54234.

Dr. Reilkoff's primary practice is M Health Fairview University of Minnesota Medical Center, at 2450 Riverside Avenue, Minneapolis, MN 55454 in Hennepin County. The practice phone is (612) 624-1765.

Dr. Reilkoff's primary practice is M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview. Dr. Reilkoff is also affiliated with M Health Fairview Southdale Hospital. The medical group on file is M Health Fairview Recovery Clinic. Dmand AI also links Dr. Reilkoff to 8 more medical groups, 6 group practices and clinics, 1 dialysis center and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Reilkoff practices, 10 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Reilkoff's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Reilkoff is board certified in critical care medicine by the American Board of Internal Medicine. Dr. Reilkoff is licensed in Minnesota.

CMS data shows 40 Medicare services from Dr. Reilkoff across 1 procedure code in 2024, for 52 Medicare patients. Medicare paid $6,113 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 52 Medicare patients who saw Dr. Reilkoff in 2024. The largest group is 75 to 84, with 19 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 38% are also on Medicaid. Their average risk score is 2.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Reilkoff's median patient age at 71, with 43% women.

In 2024, Dr. Reilkoff wrote 352 Medicare Part D claims for 26 patients. 41% of them were for generic drugs. CMS names the drug for 273 of them, across 8 drugs with 11 or more claims each, at $383,129 in total drug cost. In 2023, CMS named 188 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Reilkoff for performance year 2024, reported as part of a group. Dr. Reilkoff accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Reilkoff as offering telehealth.

Dmand AI links 4 papers to Dr. Reilkoff, published from 2023 to 2024. 2023 was the busiest year, with 2. Dr. Reilkoff's most frequent co-authors are Kathryn M. Pendleton, MD, Vikas Bansal, MD and Karyn Baum, MD.

CMS Open Payments shows 36 general payments to Dr. Reilkoff from 3 drug and device companies from 2016 to 2017. Speaker and faculty fees make up the largest share, 79% of the total. Grifols Shared Services North America, Inc. paid the most, $21,138.

Dr. Reilkoff graduated from University of North Dakota School of Medicine in 2005.